Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties. - Wikidata - wikimedia - TriplyDB

Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.

Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.

http://www.wikidata.org/entity/Q30716845

about

Gold nanoparticles functionalised with fast water exchanging Gd3+ chelates: linker effects on the relaxivity.Multimeric Near IR-MR Contrast Agent for Multimodal In Vivo Imaging.

P2860

Q30885568-269839C9-47D0-4BD9-A909-CC1704E4FDE2 Q35883228-8C7AEF76-75FA-4961-BAD5-0D9F780C7A19

P2860

Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.

http://www.wikidata.org/entity/Q30716845

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Ln[DO3A-N-α-(pyrenebutanamido) ...... ty and NIR optical properties.

@ast

Ln[DO3A-N-α-(pyrenebutanamido) ...... ty and NIR optical properties.

@en

type

label

Ln[DO3A-N-α-(pyrenebutanamido) ...... ty and NIR optical properties.

@ast

Ln[DO3A-N-α-(pyrenebutanamido) ...... ty and NIR optical properties.

@en

prefLabel

Ln[DO3A-N-α-(pyrenebutanamido) ...... ty and NIR optical properties.

@ast

Ln[DO3A-N-α-(pyrenebutanamido) ...... ty and NIR optical properties.

@en

P1433

Q30716845-435DA0CA-1A93-4D00-A219-8B6362861F33

P1476

Q30716845-62C6C727-1F43-4581-A90A-4F75CA072B99

P2093

Q30716845-4C42D1DB-2812-4CE1-8572-B4F60EF23054

Q30716845-73C9942E-D605-41B4-9C87-52451F624CE2

Q30716845-925AAFEA-4CD7-40AE-AD49-644FE39EBCB8

Q30716845-A31F7B7F-432A-4980-A823-647015907025

Q30716845-F4E472FC-6A55-4022-ADCD-82B1CF415BB5

Q30716845-F5C51183-D51B-47FE-9E3B-B3B2200BE451

P2860

Q30716845-0211BB0C-8B5D-44D8-8A69-B90F7133AD24

Q30716845-0BF6F8DD-1C1E-4999-8BE8-CDF8A426D393

Q30716845-0CAE8363-3CBA-4C48-A9F3-B56A6BA55CD3

Q30716845-117330DD-6318-41F5-8543-F4B04C9F7E6B

Q30716845-1F0535AC-810D-417B-A30B-6162403BA13B

Q30716845-1FBE01BB-9B3C-4733-95CB-0A78FAC06E03

Q30716845-22D05F77-01D7-4B82-A986-4BFA90DC6D7B

Q30716845-3187BBEE-AF4E-436E-9387-9842AE11959E

Q30716845-335E9B2A-539A-490E-ACFA-2F0566F9ACB0

Q30716845-36F40B11-473D-4209-9D64-9466E7875365

P304

Q30716845-4B283A41-C60F-4E9D-9709-B42110D4469D

P31

Q30716845-4E2CA65A-27B0-4D02-93C5-6702ADD21682

P356

Q30716845-C0545AD0-2436-428F-92D5-9D3710380505

P407

Q30716845-22B3E70E-A46A-4D33-AF52-FCB4C33D4B38

P433

Q30716845-538E8E58-AFA1-4073-A732-6E4CD491CD2C

P478

Q30716845-99520C63-C2A3-41FD-8200-F1D405A1EFB9

P50

Q30716845-09B0E2F3-3DCB-403D-BE7D-E1A700C8F6A5

Q30716845-4DC8A686-9F91-45E9-AE54-523DEE61543D

Q30716845-6EDAD2F5-8B3E-43B2-83A1-B7D431C7162D

Q30716845-A50E7AFB-B207-417F-820E-EF69BAD00AF0

P577

Q30716845-269E0FB9-CE27-449D-ACFB-68BE9A733F4B

P5875

Q30716845-E8A832A6-1850-4A90-9AC7-17ED9ECAA19E

P698

Q30716845-395A3D62-335D-4F98-BBE5-AABCBA20A6B5

P356

P1433

Dalton Transactions

P1476

Ln[DO3A-N-α-(pyrenebutanamido) ...... ity and NIR optical properties

@en

P2093

A F Martins

http://www.w3.org/2001/XMLSchema#string

C F G C Geraldes

http://www.w3.org/2001/XMLSchema#string

C I O Martins

http://www.w3.org/2001/XMLSchema#string

J A Martins

http://www.w3.org/2001/XMLSchema#string

M F Ferreira

http://www.w3.org/2001/XMLSchema#string

P M T Ferreira

http://www.w3.org/2001/XMLSchema#string

P2860

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

Amide conjugates of the DO3A-N-(α-amino)propionate ligand: leads for stable, high relaxivity contrast agents for MRI?

Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.

Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment.

Lipari-Szabo approach as a tool for the analysis of macromolecular gadolinium(III)-based MRI contrast agents illustrated by the [Gd(EGTA-BA-(CH2)12)]nn+ polymer.

The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

Supramolecular assembly of an amphiphilic Gd(III) chelate: tuning the reorientational correlation time and the water exchange rate.

Monopropionate analogues of DOTA4- and DTPA5-: kinetics of formation and dissociation of their lanthanide(III) complexes.

Gd(III)-EPTPAC16, a new self-assembling potential liver MRI contrast agent: in vitro characterization and in vivo animal imaging studies.

P304

3162-3173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C3DT52958D

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Stephané Petoud

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259350251

http://www.w3.org/2001/XMLSchema#string

P698

24343660

http://www.w3.org/2001/XMLSchema#string